Hypersecretion of calcitonin (Q39782): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed an Item |
Changed an Item |
||||||||||||||
| (One intermediate revision by the same user not shown) | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: E07.0 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 05:19, 13 August 2026
This is the process of elaborating, releasing, and oozing a 32-amino acid linear polypeptide hormone that is produced in humans primarily by the parafollicular cells (also known as C-cells) of the thyroid, and in many other animals in the ultimobranchial body.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 5A04 |
||
| English | Hypersecretion of calcitonin |
This is the process of elaborating, releasing, and oozing a 32-amino acid linear polypeptide hormone that is produced in humans primarily by the parafollicular cells (also known as C-cells) of the thyroid, and in many other animals in the ultimobranchial body. |
Statements
CID11:5A04
0 references
dki-india-5A04
0 references
Concluído
0 references
13 August 2026
0 references
